Abstract
Recently we demonstrated that a 23 kDa form of IGFBP-5, derived from osteoblast-like cells, stimulates osteoblast mitogenesis and enhances IGF-I action. Because osteoblast-derived IGFBP-5 is smaller than recombinant intact IGFBP-5 (23 vs 30 kDa) and has decreased binding affinity for IGF-I, we proposed that the native 23 kDa form of IGFBP-5 was truncated at a carboxy-terminal position. We now show that a recombinant form of carboxy-truncated IGFBP-5 binds IGF-I with reduced affinity and stimulates mitogenesis in mouse osteoblasts. We also show that 125I-truncated IGFBP-5 specifically binds to osteoblast monolayers with low binding affinity, similar to that seen with native 23 kDa IGFBP-5. These data indicate that carboxy-truncated IGFBP-5 stimulates osteoblast mitogenesis and suggest that reduced IGF-binding and cell-surface attachment are local mediators of this response.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Animals
-
Animals, Newborn
-
Base Sequence
-
Bone and Bones / cytology
-
Carrier Proteins / isolation & purification
-
Carrier Proteins / metabolism*
-
Carrier Proteins / pharmacology*
-
Cell Division / drug effects
-
Cells, Cultured
-
Humans
-
Insulin-Like Growth Factor Binding Protein 5
-
Insulin-Like Growth Factor I / metabolism*
-
Kinetics
-
Mice
-
Mitogens / pharmacology*
-
Molecular Sequence Data
-
Oligodeoxyribonucleotides
-
Osteoblasts / cytology*
-
Osteoblasts / drug effects
-
Osteosarcoma
-
Polymerase Chain Reaction / methods
-
Recombinant Proteins / isolation & purification
-
Recombinant Proteins / metabolism
-
Recombinant Proteins / pharmacology
-
Thymidine / metabolism
-
Tumor Cells, Cultured
Substances
-
Carrier Proteins
-
Insulin-Like Growth Factor Binding Protein 5
-
Mitogens
-
Oligodeoxyribonucleotides
-
Recombinant Proteins
-
Insulin-Like Growth Factor I
-
Thymidine